Integra LifeSciences

Integra LifeSciences, a leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery. Integra's orthopedic products include devices and implants for spine, foot and ankle, hand and wrist, shoulder and elbow, tendon and peripheral nerve protection and repair, and wound repair. Integra is a leader in neurosurgery, offering a broad portfolio of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care. In the United States, Integra is a leading provider of surgical instruments to hospitals, surgery centers and alternate care sites, including physician and dental offices. 
Company Growth (employees)
Type
Public
HQ
Plainsboro Center, US
Size (employees)
3,700 (est)
Integra LifeSciences is headquartered in Plainsboro Center, US

Integra LifeSciences Office Locations

Integra LifeSciences has offices in Plainsboro Center, Oakville, York, Billerica and in 1 other location
Plainsboro Center, US (HQ)
311 Enterprise Dr
West Valley City, US
3498 W 2400 S
Billerica, US
85 Rangeway Rd
York, US
589 Davies Dr
Oakville, CA
2590 Bristol Cir

Integra LifeSciences Data and Metrics

Integra LifeSciences Financial Metrics

Integra LifeSciences's revenue was reported to be $258.6 m in Q1, 2017
USD

Revenue (Q1, 2017)

258.6 m

Gross profit (Q1, 2017)

172.1 m

Gross profit margin (Q1, 2017), %

67%

Net income (Q1, 2017)

6.4 m

EBIT (Q1, 2017)

10 m

Market capitalization (22-Aug-2017)

4 b

Cash (31-Mar-2017)

124.1 m
Integra LifeSciences's current market capitalization is $4 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

836.2 m928.3 m882.7 m992.1 m

Revenue growth, %

11%(5%)12%

Cost of goods sold

334.1 m352.8 m326.5 m349.1 m

Gross profit

502.1 m575.5 m556.2 m643 m

Gross profit Margin, %

60%62%63%65%

R&D expense

58.2 m

General and administrative expense

455.6 m

Operating expense total

513.8 m

EBIT

(3.6 m)65.5 m79.6 m115.3 m

EBIT margin, %

(0%)7%9%12%

Interest expense

19.8 m22 m23.5 m25.8 m

Interest income

443 k168 k13 k24 k

Pre tax profit

(24.8 m)43 m60.7 m90.4 m

Income tax expense

(7.8 m)9 m53.8 m15.8 m

Net Income

(17 m)34 m(3.5 m)74.6 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

231.4 m229.7 m233.7 m244.1 m226.4 m236.8 m249.3 m250.3 m258.6 m

Cost of goods sold

87 m86 m86.7 m86.5 m86.1 m84.8 m89.6 m89.3 m86.6 m

Gross profit

144.4 m143.7 m146.9 m157.5 m140.3 m152 m159.7 m161 m172.1 m

Gross profit Margin, %

62%63%63%65%62%64%64%64%67%

R&D expense

13.7 m13.1 m12.6 m13.9 m13.9 m14.5 m14.7 m15.1 m15.5 m

General and administrative expense

115.3 m109.9 m114.1 m126.6 m113.4 m112 m119.2 m112.3 m142.5 m

Operating expense total

129 m123 m126.6 m140.5 m127.4 m126.4 m133.9 m127.4 m158 m

EBIT

12.4 m17.7 m16.8 m14 m10 m22.1 m22.4 m30.1 m10 m

EBIT margin, %

5%8%7%6%4%9%9%12%4%

Interest expense

5.4 m5.9 m5.5 m5.5 m6.5 m6.4 m6.6 m6.3 m5.1 m

Interest income

58 k25 k5 k8 k5 k6 k6 k2 k7 k

Pre tax profit

7.2 m11.5 m12.6 m7.6 m5.4 m15 m14.9 m25 m4.7 m

Income tax expense

2.4 m1.7 m4.2 m2.6 m37.2 m3.4 m2.2 m4.9 m(1.6 m)

Net Income

4.8 m9.8 m8.4 m5 m(31.9 m)11.6 m12.8 m20.1 m6.4 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

120.6 m72 m48.1 m102.1 m

Inventories

26.8 m29.6 m42.6 m217.3 m

Current Assets

525.2 m529.3 m438.5 m495.2 m

PP&E

200.3 m210 m205.2 m222.4 m

Goodwill

249.8 m363.9 m512.4 m510.6 m

Total Assets

1.2 b1.6 b1.8 b1.8 b

Accounts Payable

5.7 m

Current Liabilities

119.4 m126 m139.1 m123.6 m

Total Liabilities

968.3 m

Additional Paid-in Capital

779.6 m1 b798.7 m

Retained Earnings

285 m315 m145.9 m220.4 m

Total Equity

751.4 m839.7 m

Financial Leverage

2.4 x2.2 x
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

137.2 m140.2 m79.9 m131.3 m79.3 m77.1 m86.8 m107.6 m124.1 m

Inventories

223.6 m230.5 m233 m241.8 m213.9 m222 m220.4 m219.7 m239.8 m

Current Assets

564.2 m562.6 m522 m608.2 m504.9 m494.6 m494 m511.9 m568.9 m

PP&E

206.7 m203.9 m210.1 m215.5 m197.2 m210.3 m208.6 m212.2 m229.1 m

Goodwill

355 m349.6 m354.2 m357 m505.7 m516.1 m514 m515.6 m578.2 m

Total Assets

1.6 b1.5 b1.6 b1.6 b1.8 b1.8 b1.8 b1.8 b2 b

Current Liabilities

126.9 m130.1 m126.8 m155.8 m139.9 m156.6 m149.8 m161.4 m188.1 m

Additional Paid-in Capital

766.1 m769.2 m779.1 m790.4 m1 b1 b1 b1 b799.4 m

Retained Earnings

288 m297.8 m323.3 m328.3 m128 m157.6 m172.1 m192.2 m226.8 m

Total Equity

711.7 m730.1 m776.4 m794.8 m823.4 m852.5 m

Financial Leverage

2.3 x2.5 x2.4 x2.3 x2.2 x2.4 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(17 m)34 m(3.5 m)74.6 m

Depreciation and Amortization

47 m61.1 m58.9 m72.7 m

Accounts Receivable

(2.9 m)(16 m)(16 m)(17.5 m)

Inventories

(42 m)(27 m)(3.8 m)(9.6 m)

Cash From Operating Activities

53.3 m79.5 m94.5 m116.4 m

Purchases of PP&E

(47.9 m)(41.9 m)(33.4 m)(47.3 m)

Cash From Investing Activities

(50.3 m)(363.3 m)(372 m)(42.6 m)

Cash From Financing Activities

19 m242.8 m258.5 m(15.1 m)
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

4.8 m9.8 m8.4 m5 m(31.9 m)11.6 m12.8 m20.1 m6.4 m
USDY, 2017

Revenue/Employee

69.9 k

Financial Leverage

2.4 x

Integra LifeSciences Market Value History

Traffic Overview of Integra LifeSciences

Integra LifeSciences Online and Social Media Presence

Integra LifeSciences Company Life and Culture

You may also be interested in